In Brief: Guidant Mini III
This article was originally published in The Gray Sheet
Guidant Mini III: Shipments of the 48 cc, 90 g single chamber pacer/implantable cardioverter defibrillator are anticipated to commence in March. Guidant received FDA approval via premarket approval application supplement on Jan. 23 and will ramp up manufacturing capability prior to shipping, the firm states. The device is a smaller version of the firm's 59 cc, 115 g Mini II, and incorporates Guidant's new Quick Check and Quick Notes features which "allow the clinician to easily and quickly perform a comprehensive series of automatic tests and follow-up device operations" to facilitate patient management, Guidant states. The device uses Guidant's Endotak lead and Triad three-electrode energy defibrillation system...
You may also be interested in...
Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.